Published: Wed, September 13, 2017
Economy | By Melissa Porter

Alexion Pharmaceuticals to Cut 20% of Global Workforce

Alexion Pharmaceuticals to Cut 20% of Global Workforce

Proxima Capital Limited Liability Company holds 0.92% or 15,000 shares.

Alexion Pharmaceuticals, a biopharmaceutical company. Ameriprise Financial Inc. now owns 6,149,572 shares of the biopharmaceutical company's stock valued at $745,579,000 after purchasing an additional 454,069 shares in the last quarter. About 2.66M shares traded or 37.11% up from the average. United Parcel Service, Inc. ServiceNow Inc (NYSE:NOW) has risen 42.37% since September 12, 2016 and is uptrending. About 1.27 million shares traded. 215.83 million shares or 2.26% more from 211.05 million shares in 2016Q3 were reported. State Street Corp boosted its holdings in Alexion Pharmaceuticals by 6.8% in the first quarter. (NASDAQ:ALXN) for 138 shares. Alexion Pharmaceuticals, Inc. has a 52-week low of 96.18 and a 52-week high of 149.34. It has underperformed by 34.82% the S&P500. It also upped Alphabet Inc stake by 534 shares and now owns 11,790 shares.

Investors sentiment increased to 1.37 in Q4 2016. Its up 0.15, from 1.04 in 2016Q3.

A number of institutional investors have recently modified their holdings of ALXN.

Fjarde AP Fonden Fourth Swedish National Pension Fund raised its holdings in Alexion Pharmaceuticals, Inc. Winslow Ltd Liability Co reported 2.13 million shares. Federated Invsts Pa owns 578,180 shares or 0.21% of their United States portfolio.

Hantson took over as CEO at Alexion after a probe in the company's marketing practices led to the quick exit of two top execs. (NASDAQ:ALXN) or 13 shares.

Alexion Pharmaceuticals (NASDAQ:ALXN) last posted its earnings results on Thursday, July 27th. Curbstone Finance Mgmt Corp accumulated 10,875 shares or 0.51% of the stock.

Creative Planning has 17,192 shares for 0.01% of their portfolio. Moreover, Chevy Chase Trust Incorporated has 0.12% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 182,977 shares.

ServiceNow, provider of enterprise cloud computing solutions that define, structure, manage and automate services for global enterprises. Mitsubishi Ufj Company Ltd holds 250 shares. Asset One invested in 0.12% or 382,936 shares. Guggenheim Capital holds 0.14% of its portfolio in Alexion Pharmaceuticals, Inc.

Since June 14, 2017, it had 4 insider buys, and 1 sale for $235.75 million activity. Bankshares Of America Corporation De has 0.05% invested in Alexion Pharmaceuticals, Inc. PARVEN ALVIN S had sold 835 shares worth $97,511 on Thursday, June 15.

06/30/2017 - Alexion Pharmaceuticals, Inc. had its "outperform" rating reiterated by analysts at Cowen. 660,779 shares valued at $77.53 million were bought by BAKER BROS. Brean Capital maintained Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals Inc. had 71 analyst reports since July 27, 2015 according to SRatingsIntel. BMO Capital Markets maintained Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). 5,930 were reported by Conning. The company was upgraded on Friday, October 28 by Goldman Sachs. The stock presently has a consensus rating of "Buy" and an average target price of $156.32. See Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). 213,900 are held by Balyasny Asset Management Llc. (NASDAQ:ALXN) shares were bought by HANTSON LUDWIG. J.P. Morgan upgraded the shares of ALXN in report on Tuesday, September 5 to "Buy" rating. 2,000 Alexion Pharmaceuticals, Inc. The firm has "Overweight" rating given on Friday, August 25 by Barclays Capital.

Willis Investment Counsel decreased Darden Restaurants Inc (NYSE:DRI) stake by 33,500 shares to 265,050 valued at $19.27 million in 2016Q4. It also upped Celgene Corp (NASDAQ:CELG) stake by 158,200 shares and now owns 3.11 million shares. Us Bancorp (New) (NYSE:USB) was reduced too. Gutmann Kathleen M. sold $214,980 worth of stock. Five analysts have rated the stock with a hold rating, twenty have given a buy rating and three have issued a strong buy rating to the company. Therefore 76% are positive. Pacific Crest initiated the stock with "Overweight" rating in Thursday, October 8 report. The firm has "Sell" rating given on Tuesday, August 30 by Rosenblatt.

Like this: